United States News All stories

Genius Group (NYSE:GNS), an education technology company focused on entrepreneurial education and business incubation, on Monday reported audited financial results for the full year ended December 31, 2025, alongside a business update highlighting its reorganization and improving operational trajectory.

Spruce Biosciences (NASDAQ:SPRB) reported a significant reduction in annual operating expenses for 2025 on Monday, as the company successfully transitioned its clinical focus toward its enzyme replacement therapy for rare neurological disorders.

Hewlett Packard Enterprise (NYSE:HPE) reported third-quarter financial results that showcased a significant acceleration in top-line growth, fueled by robust demand for its "as-a-service" offerings and high-performance computing.

Yext (NYSE:YEXT), the New York-based software developer specializing in digital presence and search, reported a net income of $4.2 million for its fiscal fourth quarter on Monday.

Anthropic PBC filed two federal lawsuits Monday challenging the Pentagon’s decision to label the artificial intelligence startup a “supply chain risk,” an unprecedented move following the company’s refusal to permit unrestricted military use of its Claude chatbot.

Precision BioSciences (NASDAQ:DTIL) shares are in focus after the U.S. Food and Drug Administration granted Fast Track designation to PBGENE-DMD, an investigational in vivo gene editing therapy designed to treat Duchenne muscular dystrophy (DMD).

Boundless Bio (NASDAQ:BOLD) reported a narrowed net loss for the full year 2025 and a strategic realignment of its oncology pipeline, prioritizing a novel kinesin degrader as it prepares to enter the next phase of clinical development.

Hims & Hers Health (NYSE:HIMS) shares surged as much as 52% in early trading Monday after the telehealth leader announced a surprising end to its legal battle with Novo Nordisk.

Alexander’s (NYSE:ALX) on Monday announced it has entered into an agreement to sell its Rego Park I property in Queens, New York, to Northwell Health for a gross purchase price of $235.5 million.

Eltek (NASDAQ:ELTK), an Israeli manufacturer of technologically advanced printed circuit boards primarily serving defense, medical and industrial applications, on Monday reported full-year 2025 revenue of $51.8 million, an increase of 11% from the prior year.

American Express Global Business Travel (NYSE:GBTG) reported a transformative fourth quarter on Monday, as the integration of recent acquisition CWT propelled revenue up 34% to $792 million.

AbbVie (NYSE:ABBV) shares are in focus after the biopharmaceutical giant released positive topline results for its investigational obesity treatment, ABBV-295.

Sharplink (NASDAQ:SBET) reported full-year 2025 financial and operating results on Monday, marking the completion of its strategic transformation into one of the world's largest corporate holders of Ether (ETH).

Jet.AI (NASDAQ:JTAI) transitioned to profitability in 2025 as the company aggressively shifted its focus from private aviation services toward hyperscale AI data center development.

YY Group Holding (NASDAQ:YYGH), a Singapore-based provider of on-demand staffing and integrated facility management services, on Monday released preliminary, unaudited financial results for the full year ended December 31, 2025, estimating revenue in the range of $57 million to $58 million, representing year-over-year growth of approximately 38.7% to 41.1%.

Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) reported a fourth-quarter loss that was narrower than analysts anticipated, bolstered by a significant cash injection and clinical progress in its high-priority obesity and oncology programs.

Nayax (NASDAQ:NYAX) reported fourth-quarter earnings on Monday that cleared Wall Street’s profitability hurdles, even as revenue narrowly missed consensus estimates.

ZIM Integrated Shipping Services (NYSE:ZIM) reported fourth-quarter earnings on Monday that signaled a recovery in the global container market, bolstered by a strategic shift toward more fuel-efficient vessels.

W&T Offshore (NYSE:WTI) reported a fourth-quarter loss on Monday, reflecting the impact of a volatile commodity price environment even as the company successfully boosted output in the Gulf of Mexico.

FuelCell Energy (NASDAQ:FCEL) shares traded lower on Monday after the company’s first-quarter revenue failed to meet market expectations, highlighting the uneven pace of the global energy transition.

Editas Medicine (NASDAQ:EDIT) reported fourth-quarter results on Monday that significantly outpaced Wall Street projections, fueled by higher collaboration revenue and a sharp reduction in operating expenses.

3D Systems (NYSE:DDD) reported a fourth-quarter loss that underscored the ongoing volatility in the industrial manufacturing sector, even as the company saw a double-digit jump in sequential sales.

Dianthus Therapeutics (NASDAQ:DNTH) is accelerating the development of its lead immunology candidate after an interim analysis of its Phase 3 CAPTIVATE trial yielded positive results earlier than anticipated.

enCore Energy (NASDAQ:EU) reported a surge in operational output for fiscal year 2025 on Monday, as the South Texas-based producer successfully ramped up its Alta Mesa and Rosita projects to capitalize on a tightening global uranium market.